Company profile: Experic
1.1 - Company Overview
Company description
- Provider of CDMO and pharmaceutical supply services supporting products from clinical to commercial scale. Offers development, cGMP manufacturing, packaging, labeling, and global clinical trial supplies; capsule filling, powder and pellet dosing (including DPI), autoinjectors and pens; pilot spray drying; process development; analytical services; and controlled-substance storage and logistics.
Products and services
- CGMP Manufacturing Facility: cGMP-compliant site producing, packaging, labeling, and storing diverse pharmaceutical products, including controlled substances, supporting development through commercial activities with advanced manufacturing, packaging, and labeling technologies
- Pharmaceutical Development, Manufacturing & Clinical Supply Services: End-to-end programs from development to commercial scale, delivering capsule filling, powder and pellet dosing (including DPI), and autoinjector/pen packaging with clinical trial supplies
- Clinical Trial Supply Services: Global-scale support for investigational medicinal products, delivering storage, logistics, and re-labeling capabilities to manage clinical trial materials and distribution across international sites.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Experic
CSSi
HQ: United States
Website
- Description: Provider of patient recruitment and enrollment services for clinical trials, leveraging a comprehensive patient database, digital advertising, and the Research Study Rockstar software to target qualified participants near study sites. Offers site support via Local Enrollment Specialists to optimize screening and enrollment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CSSi company profile →
Target RWE
HQ: United States
Website
- Description: Provider of real-world evidence solutions evaluating drug use in hospitals and other healthcare settings, including longitudinal community registries, syndicated RWE analytics, a biorepository of 150,000+ biospecimen samples linked to de-identified clinical data, patient-generated data, advanced analytics via Population Health Research Applications, and custom epidemiological studies for development, regulatory, and post-marketing safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Target RWE company profile →
Ventus Therapeutics
HQ: United States
Website
- Description: Provider of novel small molecule medicines targeting the innate immune system to treat autoimmune and inflammatory diseases and cancer. Offers VENT-03, a first-in-class oral cGAS inhibitor in Phase 1; VENT-02, a brain-penetrant NLRP3 inhibitor in Phase 1 for neuro-inflammation and neurodegeneration; and ReSOLVE, a structural biology and computational chemistry platform for small molecule drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ventus Therapeutics company profile →
PharmaSeek
HQ: United States
Website
- Description: Provider of consulting and training solutions for clinical research sites, helping institutions, investigators, and independent sites decrease study start-up timelines by assuming administrative burdens of research management, including study identification, contract and budget negotiation, coverage analysis, and financial management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaSeek company profile →
Chiltern
HQ: United States
Website
- Description: Provider of clinical development, scientific services, and collaborative technologies for pharmaceutical and biotech companies as a contract research organization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chiltern company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Experic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Experic
2.2 - Growth funds investing in similar companies to Experic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Experic
4.2 - Public trading comparable groups for Experic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →